Chang, C.; Huang, C.-H.; Tseng, H.-J.; Yang, F.-C.; Chien, R.-N.
Real-World Experience of the One-Year Efficacy of Rifaximin Add-On to Lactulose Is Superior to Lactulose Alone in Patients with Cirrhosis Complicated with Recurrent Hepatic Encephalopathy in Taiwan. J. Pers. Med. 2021, 11, 478.
https://doi.org/10.3390/jpm11060478
AMA Style
Chang C, Huang C-H, Tseng H-J, Yang F-C, Chien R-N.
Real-World Experience of the One-Year Efficacy of Rifaximin Add-On to Lactulose Is Superior to Lactulose Alone in Patients with Cirrhosis Complicated with Recurrent Hepatic Encephalopathy in Taiwan. Journal of Personalized Medicine. 2021; 11(6):478.
https://doi.org/10.3390/jpm11060478
Chicago/Turabian Style
Chang, Ching, Chien-Hao Huang, Hsiao-Jung Tseng, Fang-Chen Yang, and Rong-Nan Chien.
2021. "Real-World Experience of the One-Year Efficacy of Rifaximin Add-On to Lactulose Is Superior to Lactulose Alone in Patients with Cirrhosis Complicated with Recurrent Hepatic Encephalopathy in Taiwan" Journal of Personalized Medicine 11, no. 6: 478.
https://doi.org/10.3390/jpm11060478
APA Style
Chang, C., Huang, C.-H., Tseng, H.-J., Yang, F.-C., & Chien, R.-N.
(2021). Real-World Experience of the One-Year Efficacy of Rifaximin Add-On to Lactulose Is Superior to Lactulose Alone in Patients with Cirrhosis Complicated with Recurrent Hepatic Encephalopathy in Taiwan. Journal of Personalized Medicine, 11(6), 478.
https://doi.org/10.3390/jpm11060478
